Here, interaction with mesenchymal stromal cells in the metastatic niche may elicit a state of dormancy through BMPs and growth-arrest specific-6 (GAS6) protein secreted by the niche, permitting tumor cells to escape from anti-cancer drugs and immune therapy and emerge years to decades later as a clinically detectable bone metastasis [365,366]. The gene discussed is CLN5; the disease is cancer.